Literature DB >> 16412101

PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Olivier Boutaud1, Thomas J Montine, Lei Chang, William L Klein, John A Oates.   

Abstract

The body of evidence indicating that oligomers of amyloid beta(1-42) (Abeta(1-42)) produce toxicity to neurons, together with our demonstration that prostaglandin H(2) (PGH(2)) oligomerizes amyloid beta(1-42), led to the examination of the neurotoxicity of amyloid beta(1-42) treated with PGH(2). The neurotoxic effects of Abeta(1-42) incubated with PGH(2) was examined in primary cultures of cerebral neurons of mice, monitoring the reduction of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as an indicator of cell toxicity. Whereas Abeta(1-42) itself, incubated for 24 h, has little or no effect on MTT reduction, Abeta(1-42) 24 h after exposure to PGH(2) produced a marked inhibition of MTT reduction, comparable with the inhibition resulting from Abeta(1-42) that has been oligomerized by incubation for 6 days. Similar results were obtained when Abeta(1-42) was incubated with levuglandin E(2) (LGE(2)), a reactive aldehyde formed by spontaneous rearrangement of PGH(2). The oligomers formed from reaction of Abeta(1-42) with LGE(2) exhibit immunochemical similarity with amyloid-derived diffusible ligands (ADDLs), as determined by analysis of the products of reaction of Abeta(1-42) with LGE(2) using western blotting with an antibody that is selective for ADDLs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412101      PMCID: PMC1621054          DOI: 10.1111/j.1471-4159.2005.03586.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

Authors:  E Hughes; R M Burke; A J Doig
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

3.  Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

Authors:  B A in t' Veld; A Ruitenberg; A Hofman; L J Launer; C M van Duijn; T Stijnen; M M Breteler; B H Stricker
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

4.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

5.  Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.

Authors:  G P Lim; F Yang; T Chu; E Gahtan; O Ubeda; W Beech; J B Overmier; K Hsiao-Ashec; S A Frautschy; G M Cole
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

6.  Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

Authors:  G P Lim; F Yang; T Chu; P Chen; W Beech; B Teter; T Tran; O Ubeda; K H Ashe; S A Frautschy; G M Cole
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

7.  Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.

Authors:  Olivier Boutaud; David M Aronoff; Jacob H Richardson; Lawrence J Marnett; John A Oates
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.

Authors:  O Boutaud; C J Brame; P Chaurand; J Li; S W Rowlinson; B C Crews; C Ji; L J Marnett; R M Caprioli; L J Roberts; J A Oates
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

9.  Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice.

Authors:  K I Andreasson; A Savonenko; S Vidensky; J J Goellner; Y Zhang; A Shaffer; W E Kaufmann; P F Worley; P Isakson; A L Markowska
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

10.  Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

Authors:  M P Lambert; K L Viola; B A Chromy; L Chang; T E Morgan; J Yu; D L Venton; G A Krafft; C E Finch; W L Klein
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

View more
  27 in total

1.  On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometry.

Authors:  Almary Chacon; Irene Zagol-Ikapitte; Venkataraman Amarnath; Michelle L Reyzer; John A Oates; Richard M Caprioli; Olivier Boutaud
Journal:  J Mass Spectrom       Date:  2011-08       Impact factor: 1.982

2.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

Review 3.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

4.  Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.

Authors:  Nathaniel S Woodling; Qian Wang; Prachi G Priyam; Paul Larkin; Ju Shi; Jenny U Johansson; Irene Zagol-Ikapitte; Olivier Boutaud; Katrin I Andreasson
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

5.  Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studies.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Satyawan Jadhav; John A Oates; Olivier Boutaud
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-21       Impact factor: 3.205

Review 6.  The rise and fall of anandamide: processes that control synthesis, degradation, and storage.

Authors:  Roger Gregory Biringer
Journal:  Mol Cell Biochem       Date:  2021-03-13       Impact factor: 3.396

7.  Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.

Authors:  Sean S Davies; Chris Bodine; Elena Matafonova; Brooke G Pantazides; Nathalie Bernoud-Hubac; Fiona E Harrison; Sandra J Olson; Thomas J Montine; Venkataraman Amarnath; L Jackson Roberts
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Soluble state high resolution atomic force microscopy study of Alzheimer's beta-amyloid oligomers.

Authors:  Gajendra S Shekhawat; Mary P Lambert; Saurabh Sharma; Pauline T Velasco; Kirsten L Viola; William L Klein; Vinayak P Dravid
Journal:  Appl Phys Lett       Date:  2009-11-06       Impact factor: 3.791

Review 9.  Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).

Authors:  K L Viola; P T Velasco; W L Klein
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

10.  Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Wei Li; Robert G Salomon; Laura E Nagy
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.